PBYI SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

10-Q/A

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Puma Biotechnology Reports Third Quarter 2026 Financial Results and Raises Full Year Net Income Guidance

Nov 5, 2026

8-K

Puma Biotechnology Reports Q2 2026 Financial Results and Raises 2026 Guidance

Aug 6, 2026

8-K

Puma Biotechnology, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 16, 2026

8-K

Puma Biotechnology Reports Q1 2026 Financial Results and Raises Full Year 2026 Guidance

May 7, 2026

8-K

Puma Biotechnology Reports Q4 and Full Year 2025 Financial Results, Showing Continued Profitability

Feb 26, 2026

8-K

Puma Biotechnology Reports Third Quarter 2025 Financial Results; raises 2025 NERLYNX revenue and net income estimates

Nov 6, 2025

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 27, 2024

S-3

SHARE RESALE REGISTRATION | Shares amount: 1,792,114 | Share price: $3.22 EFFECTIVE

Jul 22, 2022

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 16, 2021

S-3

SHELF | Offering amount: $50,000,000.00 EFFECTIVE

Jul 2, 2021

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 27, 2020

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 19, 2017

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 28, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 28, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 7, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 28, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 28, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 26, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13D/A

AUERBACH ALAN H (Filed by)

Oct 6, 2026

WILSON TROY EDWARD (Reporting)

Sep 16, 2026

Cesano Alessandra (Reporting)

Sep 16, 2026

144

Form 144 - Report of proposed sale of securities

Sep 14, 2026

144

Form 144 - Report of proposed sale of securities

Sep 14, 2026

AUERBACH ALAN H (Reporting)

Jul 8, 2026

Other

TYPE

HEADLINE

FILED AT

Puma Biotechnology, Inc. PBYI · SEC Filings